Cell and Gene Therapy (CAGT)

Expert services to stay ahead of advancing science

The use of alternative treatments such as Cell and Gene Therapies (CAGT) holds great potential for bridging the gaps left by traditional treatments. These innovative CAGT clinical development programs require a suite of complex laboratory assessments to satisfy regulatory submissions and support Proof of Mechanism, Pharmacodynamic, Safety and Efficacy investigations. IQVIA Laboratories with its global laboratory network and industry leading subject matter experts, is ideally positioned to shape, validate, and deliver those biomarker assessments. IQVIA Laboratories can provide flexible, integrated Cell and Gene Therapy development solutions throughout the drug development journey, beginning with the pre-clinical phase and continuing through post-approval.

IQVIA Laboratories offers an extensive array of CAGT laboratory solutions to meet the unique demands of CAGT clinical development

Industry-Leading Technology and Expertise with a Global Footprint

Genomics technology

We quickly design and validate potential therapeutics and can accommodate early safety testing with specialized assays, including ddPCR, Next Generation Sequencing and single-cell portfolio.

Thought leadership

We offer not only laboratory testing but also expertise in the design, validation, and choosing the correct assay for your specific need.

Global assays

We develop customized assays in our North Carolina laboratory and transfer them seamlessly to Beijing and other laboratories around the world.